The effect of an educational intervention on meperidine use in Nova Scotia, Canada: A time series analysis

Pharmacoepidemiology and Drug Safety

Volumn 21, Issue 2, 2012, Pages 177-183

  Fisher, Judith E ^a   Zhang, Ying ^b   Sketris, Ingrid ^a   Johnston, Grace ^a   Burge, Fred ^c  

^a DALHOUSIE UNIVERSITY   (Canada)

^b ACADIA UNIVERSITY   (Canada)

^c DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Educational intervention; Meperidine; Pethidine; Time series analysis

Indexed keywords

PETHIDINE;

ARTICLE; CANADA; DRUG USE; HUMAN; MEDICAL AUDIT; MEDICAL EDUCATION; OUTCOME ASSESSMENT; PHARMACY; PRESCRIPTION; PRIORITY JOURNAL; TIME SERIES ANALYSIS;

ADMINISTRATION, ORAL; ANALGESICS, OPIOID; COMMUNITY PHARMACY SERVICES; EDUCATION, MEDICAL, CONTINUING; FEEDBACK; HUMANS; MEDICAL AUDIT; MEPERIDINE; MODELS, STATISTICAL; NOVA SCOTIA; OUTCOME ASSESSMENT (HEALTH CARE); PHYSICIAN'S PRACTICE PATTERNS; RISK;

EID: 84856265435     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.2259     Document Type: Article

References (45)

1. Latta KS, Ginsberg B, Barkin RL. Meperidine: A critical review. Am J Ther 2002;9:53-68.
2. Kornitzer BS, Manace LC, Fischberg DJ, Leipzig RM. Prevalence of meperidine use in older surgical patients. Arch Surg 2006;141:76-81.
3. Karunatilake H, Buckley NA. Severe neurotoxicity following oral meperidine (pethidine) overdose. Clin Toxicol (Phila) 2007;45:200-201.
4. Pain management panel: Management of cancer pain: Clinical practice guideline no. 9 AHCPR publication no. 94-0592. Agency for Health Care Policy and Research, Public Health Service, US Department of Health and Human Services: Rockville, MD, 1994; 94-0592.
5. Acute pain management panel: Acute pain management: Operative or medical procedures and trauma. Clinical practice guideline. AHCPR publication no. 92-0032. Agency for Health Care Policy and Research, Public Health Service, US Department of Health and Human Services: Rockville, MD, 1992; 92-0032.
6. American Pain Society Principles of Analgesic Use in the Treatment of Acute Pain and Cancer Pain. 5th edn, American Pain Society: Glenview, Illinois, 2003.
7. The Joint Commission on Accreditation of Healthcare Organizations, The National Pharmaceutical Council. Pain: Current understanding of assessment, management and treatment. The Joint Commission on Accreditation of Healthcare Organizations; The National Pharmaceutical Council; 2001. (accessed July 25, 2011)
8. Golembiewski J. Safety concerns with meperidine. J Perianesth Nurs 2002;17:123-125.
9. Baker DE. Meperidine: A drug past its prime. Hosp Pharm 2001;36:1131-1132.
10. R): Issues in medication safety. ISMP Canada Safety Bulletin 2004;4:1.
11. Safe Use of Medications - Demerol. Available at: Accessed September 21, 2009.
12. Gordon DB, Jones HD, Goshman LM, Foley DK, Bland SE. A quality improvement approach to reducing use of meperidine. Jt Comm J Qual Improv 2000;26:686-699.
13. Hinnant DC. Minimizing meperidine use. Am J Nurs 1996;96:18.
14. O'Connor A, Schug SA, Cardwell H. A comparison of the efficacy and safety of morphine and pethidine as analgesia for suspected renal colic in the emergency setting. J Accid Emerg Med 2000;17:261-264.
15. Taylor SE, Braitberg G, Lugt J. Multifaceted education initiative minimizes pethidine prescribing in the emergency department. Emerg Med Australas 2007;19:25-30.
16. Seifert CF, Kennedy S. Meperidine is alive and well in the new millennium: Evaluation of meperidine usage patterns and frequency of adverse drug reactions. Pharmacotherapy 2004;24:776-783.
17. Gilson AM, Kreis PG. The burden of the nonmedical use of prescription opioid analgesics. Pain Med 2009;10(Suppl 2):S89-S100.
18. Drug abuse warning network, 2006: National estimates of drug-related Emergency Department visits. U.S. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Office of Applied Studies: Rockville, MD, 2008; DAWN Series D-30, DHHS Publication No. (SMA) 08-4339. (accessed July 25, 2011)
19. Minister of Justice, Government of Canada. Controlled drugs and substances act; S.C., 1996, c. 19. (Accessed November 27, 2010)
20. Nova Scotia Prescription Monitoring Program. Nova Scotia prescription monitoring program operational policies. In Nova Scotia Prescription Monitoring Program: Policy and Reference Materials. Nova Scotia Prescription Monitoring Program: Halifax, Nova Scotia, 2008; pp. 17-21.
21. Pellerin D. Manager, Nova Scotia Prescription Monitoring Program. Personal Communication, July 27, 2011.
22. O'Connor AB, Lang VJ, Quill TE. Eliminating analgesic meperidine use with a supported formulary restriction. Am J Med 2005;118:885-889.
23. Pellerin D. Manager, Nova Scotia Prescription Monitoring Program. Personal Communication, November 29, 2010.
24. Statistics Canada. Table051-0001 - Estimates of population, by age group and sex for July 1, Canada, provinces and territories, annual (persons unless otherwise noted). (accessed October 27, 2010)
25. Canadian Institute for Health Information. Supply, Distribution and Migration of Canadian Physicians. (accessed January 17, 2011)
26. Nova Scotia Prescription Monitoring Program, About us: History. Available at: (accessed June 22, 2010)
27. Cleveland WS. Lowess - a program for smoothing scatterplots by robust locally weighted regression. Am Stat 1981;35:54-54.
28. Box GEP, Tiao GC. Intervention analysis with applications to economic and environmental problems. J Am Stat Assoc 1975;70:70-79.
29. Hipel K, Mcleod AI. Time Series Modelling of Water Resources and Environmental Systems. Elsevier: Amsterdam, 1994.
30. Wensing M, Grol RP. Educational interventions. In Improving Patient Care. the Implementation of Change in Clinical Practice Grol RP, Wensing M, Eccles M (eds.). Elseveir Butterworth Heinemann: London, 2005; p. 147.
31. Grol R, Grimshaw J. From best evidence to best practice: Effective implementation of change in patients' care. Lancet 2003;362:1225-1230.
32. Grimshaw JM, Thomas RE, MacLennan G, et al. Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technol Assess 2004;8(iii-iv): 1-72.
33. Grimshaw JM, Shirran L, Thomas R, et al. Changing provider behavior: An overview of systematic reviews of interventions. Med Care 2001;39:II2-II45.
34. Lowe DO, Lummis H, Zhang Y, Sketris IS. Effect of educational and policy interventions on institutional utilization of wet nebulization respiratory drugs and portable inhalers. Can J Clin Pharmacol 2008;15:e334-e343.
35. van der Weijden T, Grol R. Feedback and reminders. In Improving Patient Care. the Implementation of Change in Clinical Practice Grol R, Wensing M, Eccles M (eds.). Elsevier Butterworth Heinemann: London, UK, 2005; pp. 158.
36. Gill PS, Makela M, Vermeulen KM, et al. Changing doctor prescribing behaviour. Pharm World Sci 1999;21:158-167.
37. Health Canada. Drug Product Online Query. Available at: (accessed February 11, 2011)
38. Ontario Drug Benefit Formulary/Comparative drug index no. 41. Toronto ON: Queen's Printer; 2008. (accessed July 26, 2011)
39. Canadian Institute for Health Information. Drug expenditure in Canada, 1985 to 2009. Canadian Institute for Health Information: Ottawa; 2010. (accessed February 25, 2011).
40. Government of Nova Scotia, Department of Health and Wellness, Nova Scotia Pharmacare. Available at: (accessed February 25, 2011)
41. Elshaug AG, Hiller JE, Moss JR. Exploring policy-makers' perspectives on disinvestment from ineffective healthcare practices. Int J Technol Assess Health Care 2008;24:1-9.
42. Elshaug AG, Hiller JE, Tunis SR, Moss JR. Challenges in Australian policy processes for disinvestment from existing, ineffective health care practices. Aust New Zealand Health Policy 2007;4:23.
43. Elshaug AG, Moss JR, Littlejohns P, Karnon J, Merlin TL, Hiller JE. Identifying existing health care services that do not provide value for money. Med J Aust 2009;190:269-273.
44. McWilliam CL, Kothari A, Ward-Griffin C, Forbes D, Leipert B, South West Community Care Access Centre Home Care Collaboration (SW-CCAC). Evolving the theory and praxis of knowledge translation through social interaction: A social phenomenological study. Implement Sci 2009;4:26.
45. McLeod AI, Vingilis ER. Power computations for intervention analysis. Technometrics 2005;47:174-185.